Buscar
Mostrando ítems 1-10 de 37
Practical guidelines for diagnosis and treatment of acromegaly
(Elsevier, 2013-10)
[Abstract] Acromegaly and gigantism are due to excess GH secretion, usually by a pituitary adenoma. It is an uncommon disease.
Diagnosis is made by showing elevated GH and IGF-I levels in patients with a clinical picture ...
Clinical significance of T2-weighted sequence intensity on magnetic resonance imaging in clinically non-functioning pituitary adenomas
(Thieme, 2023-12)
[Abstract] Background Little is known about the relationship between signal intensity patterns on T2-weighted magnetic resonance imaging (MRI) in non-functioning pituitary adenomas (NFPAs).
Objective In this study, the ...
Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications
(Hindawi, 2010)
[Abstract] Ghrelin is a 28-amino-acid peptide that displays a strong growth hormone- (GH-) releasing activity through the activation of the growth hormone secretagogue receptor (GHSR). The first studies about role of ghrelin ...
Assessing motivational stages and processes of change for weight management around bariatric surgery: a multicenter study
(Springer Nature, 2019-06-17)
[Abstract] Introduction/purpose: The assessment of the patients' motivation as a predictor of behavioral change via five stages (pre-contemplation, contemplation, preparation, action, and maintenance) and four processes ...
Serum levels of the adipomyokine irisin in patients with chronic kidney disease
(Elsevier, 2016-12-14)
[Abstract] Background. Irisin is an adipomyokine with claimed anti-obesity and anti-diabetic effects. This hormone has been insufficiently studied in patients with advanced chronic kidney disease (CKD).
Objective. To ...
Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study
(Springer, 2019-02-13)
[Abstract] PURPOSE: The burden of chronic daily subcutaneous administration of pegvisomant on adherence has not been previously studied. This study was aimed to determine the adherence to pegvisomant treatment in acromegaly ...
Treatment with growth hormone for adults with growth hormone deficiency syndrome: benefits and risks
(MDPI, 2018-03-17)
[Abstract] Pharmacological treatment of growth hormone deficiency (GHD) in adults began in clinical practice more than 20 years ago. Since then, a great volume of experience has been accumulated on its effects on the ...
Alteración de la expresión génica de Sor1 y RB1 en distintos modelos de estrés metabólico
(Sociedad Española para el Estudio de la Obesidad (SEEDO), 2018)
Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
(MDPI, 2022-02-28)
[Abstract] The most common endocrine disease in obesity is hypothyroidism and secondary endocrine alterations, including abnormal thyroid function, are frequent in obesity. It is unclear whether impaired thyroid function ...
Adenoma hipofisiario no funcionante: estudio clínico y patológico
(Elsevier, 2016)